Marco Manfredini

Dr. Marco Manfredini

Dermatology Unit, Department of Surgical, Medical, Dental and Morphological Sciences related to Transplant, Oncology and Regenerative Medicine, University of Modena and Reggio Emilia, Modena, Italy
orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2018 in JAMA Dermatology
Verified
Journal Article
Open access
PDF file
Aimilios LallasAimilios Lallas
Aimilios Lallas
CLCaterina Longo
Caterina Longo
MMMarco Manfredini
Marco Manfredini
EBElisa Benati
Elisa Benati
GBGraziella Babino
Graziella Babino
GAGiuseppe Argenziano
Giuseppe Argenziano
Dermoscopy is nowadays considered an essential tool for melanoma detection because its use significantly increases the ability of clinicians to recognize melanoma earlier. This early detection is because dermoscopy reveals the natural asymmetry of melanoma before it becomes clinically evident.1,2

1 October 2015 in JAMA Dermatology
Verified
Journal Article
Open access
PDF file
FFFrancesca Farnetani
Francesca Farnetani
ASAlon Scope
Alon Scope
RBRalph P. Braun
Ralph P. Braun
SGSalvador Gonzalez
Salvador Gonzalez
PGPascale Guitera
Pascale Guitera
GPGiovanni Pellacani
Giovanni Pellacani
Research from JAMA Dermatology — Skin Cancer Diagnosis With Reflectance Confocal Microscopy — Reproducibility of Feature Recognition and Accuracy of Diagnosis

1 April 2018 in Clinica Chimica Acta
Verified
Journal Article
Closed access
GPGiovanni Ponti
Giovanni Ponti
MMMonia Maccaferri
Monia Maccaferri
MMMarco Manfredini
Marco Manfredini
Shaniko KaleciShaniko Kaleci
Shaniko Kaleci
Mauro MandrioliMauro Mandrioli
Mauro Mandrioli
ATAldo Tomasi
Aldo Tomasi

5 November 2018 in Journal of the European Academy of Dermatology and Venereology
Verified
Journal Article
Closed access
PDF file
VBVincenzo Bettoli
Vincenzo Bettoli
MMMarco Manfredini
Marco Manfredini
LML. Massoli
L. Massoli
CCC. Carillo
C. Carillo
ABA. Barozzi
A. Barozzi
MCM. Corazza
M. Corazza

1 September 2019 in Critical Reviews in Oncology/Hematology
Verified
Journal Article
Open access
GPGiovanni Ponti
Giovanni Ponti
MMMarco Manfredini
Marco Manfredini
ATAldo Tomasi
Aldo Tomasi
Liquid biopsy can quantify and qualify cell-free (cfDNA) and tumour-derived (ctDNA) DNA fragments in the bloodstream. CfDNA quantification and mutation analysis can be applied to diagnosis, follow-up and therapeutic management as novel oncologic biomarkers. However, some tumor-types release a low amount of DNA into the bloodstream, hampering diagnosis through standard liquid biopsy procedures. Several tumors, as such as brain, kidney, prostate, and thyroid cancer, are in direct contact with other body fluids and may be alternative sources for cfDNA and ctDNA. Non-blood sources of cfDNA/ctDNA useful as novel oncologic biomarkers include cerebrospinal fluids, urine, sputum, saliva, pleural effusion, stool and seminal fluid. Seminal plasma cfDNA, which can be analyzed with cost-effective procedures, may provide powerful information capable to revolutionize prostate cancer (PCa) patient diagnosis and management. In the near future, cfDNA analysis from non-blood biological liquids will become routine clinical practice for cancer patient diagnosis and management.

4 August 2017 in Journal of the European Academy of Dermatology and Venereology
Verified
Journal Article
Open access
PDF file
MMMarco Manfredini
Marco Manfredini
CLCaterina Longo
Caterina Longo
BFB. Ferrari
B. Ferrari
SPS. Piana
S. Piana
EBE. Benati
E. Benati
EMElvira Moscarella
Elvira Moscarella
Background: Squamous cell carcinoma (SCC) of the skin is a highly prevalent neoplasm. The management and the prognosis of this tumour are dependent on its invasiveness and its grade of differentiation.Objectives: To evaluate whether specific dermoscopic and reflectance confocal microscopy (RCM) criteria can predict the diagnosis of invasiveSCCvs.in situSCCand poorly differentiated compared with well‐ and moderately differentiatedSCC.Methods: Dermoscopic andRCMimages ofSCCwere retrospectively evaluated for the presence of predefined criteria.Results: Among 143SCCs, 121 cases had a complete set of images and thus were included in the study set. The head and neck area was the most frequently involved body site (74/121; 61.1%) followed by extremities (36/121, 29.7%) and trunk (11/121, 9.1%). Seventy tumours werein situ(57.8%), while 51 were invasive (42.1%), of these 11 were poorly differentiated (21.5%), 16 were moderately differentiated (31.3%), and 24 were well differentiated (47.0%). Chi‐squared analysis demonstrated that invasiveSCCs were characterized by polymorphic vessels, erosion/ulceration, architectural disarrangement, speckled nucleated cells in the dermis, irregularly dilated vessels and absence of hyperkeratosis. Buttonhole vessels, white structureless areas and dotted or glomerular vessels were significantly associated within situlesions. Poorly differentiatedSCCs were typified by red areas, erosion/ulceration and architectural disarrangement. Well‐ or moderately differentiatedSCCs were associated with white areas and speckled nucleated cells in the epidermis.Conclusion: Clinical, dermoscopic andRCMimages provide useful information that should be integrated in order to achieve the optimal therapeutic management for the patient.